Sichuan Creed, the only short-acting muscle relaxant in China, won the first imitation!

According to the latest data from Meinnet.

Muscle relaxant "Yi Ge" is included in centralized procurement, and the market for over 4 billion is shuffled

Muscle relaxants (hereinafter referred to as muscle relaxants) can selectively act on neuromuscular junctions, temporarily interfering with normal neuromuscular excitement transmission, and causing muscle relaxation

Muscle relaxants are mainly used in general anesthesia.

With the continuous increase in the number of hospitalizations and operating units in China's medical institutions, the muscle relaxant market is expanding year by year

Figure 1: Sales of terminal muscle relaxants in public medical institutions in China (unit: ten thousand yuan)

Source: Mi Nei.

The market concentration of muscle relaxants in China's public medical institutions is relatively high.

Subdivided into anesthesiology muscle relaxants, non-depolarizing muscle relaxants are the most clinically used category.

Table 1: Sales of commonly used muscle relaxants in terminal anesthesia departments of public medical institutions in China in 2021H1

Source: Mi Nei.

At present, Cisatracurium Benzene Sulfonium Injection (including Cisatracurium Benzene Sulfonium Injection and Cisatracurium Benzene Sulfonium Injection) has been included in the fifth batch of national centralized procurement, and the number of companies that have been evaluated for Rocuronium Bromide Injection There are already 4 companies, with a high probability of being selected for the seventh batch of centralized procurement

Table 2: Muscle relaxants that have been included in the national collection

Source: Shanghai Sunshine Pharmaceutical Purchasing Network

The only short-acting muscle relaxant, Sichuan Creed won the first imitation

According to data from Minaiwang, there are currently six muscle relaxant companies that have passed or deemed to have passed the consistency evaluation, including Sichuan Creed Pharmaceutical’s Micuronium Chloride Injection, and Livzon Group’s Livzon Pharmaceutical Factory’s Dantrolene Sodium for Injection.

Table 3: Partial over-assessment of muscle relaxants (including new classifications for production)

Source: Meinenet MED2.

Micuronium chloride is highly selective and the only non-depolarizing neuromuscular blocker that does not require anticholinesterase antagonism.

Sichuan Creed Pharmaceutical's Micuronium Chloride Injection was approved for production in April 2021, and it is the first domestic imitation.

In terms of muscle relaxants, Sichuan Creed Pharmaceuticals has created anesthesia line products with different effects and durations.

Note: The original text has been deleted

Source: Minet database